Skip to Content

Month: November 2020

Christopher Krebs

Trump fires top security official who vouched for 2020 election as he pushes unsubstantiated claims of fraud after loss

WASHINGTON, DC — President Donald Trump has fired the director of the federal agency that repeatedly vouched for the reliability of the 2020 election. Christopher Krebs, a Trump appointee, was the first director of the U.S. Cybersecurity and Infrastructure Security Agency. He ran the agency from its creation in the wake of Russian interference with

Continue Reading

These GOP governors long resisted mask mandates and coronavirus rules. Now their states are in crisis.

Since Covid-19 hit US shores, Republican governors in the Upper Midwest and Northern Plains have largely taken a hands-off approach. The results of that strategy have been poor. When adjusted for population, no states have had more new Covid-19 infections, hospitalizations and deaths over the past seven days than North and South Dakota. The nearby

Continue Reading

These GOP governors long resisted mask mandates and coronavirus rules. Now their states are in crisis.

Since Covid-19 hit US shores, Republican governors in the Upper Midwest and Northern Plains have largely taken a hands-off approach. The results of that strategy have been poor. When adjusted for population, no states have had more new Covid-19 infections, hospitalizations and deaths over the past seven days than North and South Dakota. The nearby

Continue Reading

Almost 1 in 10 transgender Americans use nonprescribed hormones because they’re uninsured or insurance won’t cover the cost

For the transgender people who seek it, gender-affirming hormone therapy can be lifesaving. But if they’re uninsured or their insurance won’t cover it, some bypass the health care system entirely to get the care they need. Around 75,000 transgender Americans are likely using hormones that weren’t prescribed — close to 1 in 10 of the

Continue Reading

Pfizer has enough safety data about its coronavirus vaccine and is preparing to submit for FDA authorization, CEO says

Pfizer has accumulated enough safety data on its Covid-19 vaccine and is preparing to file for emergency use authorization from the US Food and Drug Administration, company CEO Albert Bourla said Tuesday. Last week, the company released early clinical trial data showing its vaccine is more than 90% effective, and said it was waiting to

Continue Reading